BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35651922)

  • 21. Association between polymorphisms of the
    He XT; Xu HQ; Wang XM; He XS; Niu JQ; Gao PJ
    World J Gastroenterol; 2017 Jan; 23(2):232-241. PubMed ID: 28127197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Verification of hepatitis B-related hepatocellular carcinoma predictive models to evaluate the risk of HCC in patients with liver cirrhosis under antiviral treatment.
    Huang X; Wang H; Zhang W; Gu E
    Eur J Gastroenterol Hepatol; 2022 May; 34(5):546-552. PubMed ID: 35170528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection.
    Deng H; Fan X; Wang X; Zeng L; Zhang K; Zhang X; Li N; Han Q; Lv Y; Liu Z
    Sci Rep; 2020 Nov; 10(1):20276. PubMed ID: 33219288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
    Yang HI; Sherman M; Su J; Chen PJ; Liaw YF; Iloeje UH; Chen CJ
    J Clin Oncol; 2010 May; 28(14):2437-44. PubMed ID: 20368541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. External validation of hepatocellular carcinoma risk scores in patients with chronic hepatitis B virus infection in China.
    Lou T; Li B; Xiong P; Jin C; Chen Y
    J Viral Hepat; 2021 Oct; 28(10):1373-1380. PubMed ID: 34218498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole-genome DNA methylation and hydroxymethylation profiling for HBV-related hepatocellular carcinoma.
    Ye C; Tao R; Cao Q; Zhu D; Wang Y; Wang J; Lu J; Chen E; Li L
    Int J Oncol; 2016 Aug; 49(2):589-602. PubMed ID: 27221337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood gene signature for early hepatocellular carcinoma detection in patients with chronic hepatitis B.
    Omar H; Lim CR; Chao S; Lee MM; Bong CW; Ooi EJ; Yu CG; Tan SS; Abu Hassan MR; Menon J; Muthukaruppan R; Singh M; Nik Abdullah NA; Ooi BP; Ding RP; Low EJ; Tan F; Novak D; Harris DF; Yang H; Merican I; Liew CC
    J Clin Gastroenterol; 2015 Feb; 49(2):150-7. PubMed ID: 25569223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. APS (Age, Platelets, 2D Shear-Wave Elastography) Score Predicts Hepatocellular Carcinoma in Chronic Hepatitis B.
    Zhang T; Zhang G; Deng X; Zeng J; Jin J; Zeping H; Wu M; Zheng R
    Radiology; 2021 Nov; 301(2):350-359. PubMed ID: 34427463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Moderate levels of serum hepatitis B virus DNA are associated with the highest risk of hepatocellular carcinoma in chronic hepatitis B patients.
    Kim GA; Han S; Choi GH; Choi J; Lim YS
    Aliment Pharmacol Ther; 2020 Jun; 51(11):1169-1179. PubMed ID: 32291781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic variants in class II transactivator are associated with chronic hepatitis B virus infection in the Han Chinese population.
    Su M; Chen Z; Zheng J; Chen Y
    Int J Immunogenet; 2020 Oct; 47(5):435-442. PubMed ID: 32103629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
    Tang Y; Zhang Y; Hu X
    Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [High-performance liquid chromatography-mass spectrometry-based serum metabolic profiling in patients with HBV-related hepatocellular carcinoma].
    Zhang L; Fan Z; Kang H; Wang Y; Liu S; Shan Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jan; 39(1):49-56. PubMed ID: 30692066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble Axl Is a Novel Diagnostic Biomarker of Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection.
    Song X; Wu A; Ding Z; Liang S; Zhang C
    Cancer Res Treat; 2020 Jul; 52(3):789-797. PubMed ID: 32138467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying Potential New Gene Expression-Based Biomarkers in the Peripheral Blood Mononuclear Cells of Hepatitis B-Related Hepatocellular Carcinoma.
    Poortahmasebi V; Nejati A; Abazari MF; Nasiri Toosi M; Ghaziasadi A; Mohammadzadeh N; Tavakoli A; Khamseh A; Momenifar N; Gholizadeh O; Norouzi M; Jazayeri SM
    Can J Gastroenterol Hepatol; 2022; 2022():9541600. PubMed ID: 35265561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gamma-glutamyl transpeptidase-to-platelet ratio and the fibrosis-4 index in predicting hepatitis B virus-related hepatocellular carcinoma development in elderly chronic hepatitis B patients in China: A single-center retrospective study.
    Zhu YF; Tan YF; Xu X; Zheng JL; Zhang BH; Tang HR; Yang JY
    Medicine (Baltimore); 2019 Dec; 98(50):e18319. PubMed ID: 31852119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of STAT3 rs1053004 single nucleotide polymorphism in patients with chronic hepatitis B and hepatocellular carcinoma.
    Fatemipour M; Arabzadeh SAM; Molaei H; Geramizadeh B; Dabiri S; Fatemipour B; Vahedi SM; Malekpour Afshar R
    Cell Mol Biol (Noisy-le-grand); 2017 Dec; 63(12):45-50. PubMed ID: 29307341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypomethylation of the cyclin D1 promoter in hepatitis B virus-associated hepatocellular carcinoma.
    Liu HH; Fang Y; Wang JW; Yuan XD; Fan YC; Gao S; Han LY; Wang K
    Medicine (Baltimore); 2020 May; 99(20):e20326. PubMed ID: 32443384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients.
    Lee HW; Ahn SH
    World J Gastroenterol; 2016 Oct; 22(37):8314-8321. PubMed ID: 27729738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.
    Li S; Deng Y; Chen ZP; Huang S; Liao XC; Lin LW; Li H; Peng T; Qin X; Zhao JM
    Infect Genet Evol; 2011 Dec; 11(8):2083-8. PubMed ID: 22019522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B Virus Combo Mutations Improve the Prediction and Active Prophylaxis of Hepatocellular Carcinoma: A Clinic-Based Cohort Study.
    Yin J; Wang J; Pu R; Xin H; Li Z; Han X; Ding Y; Du Y; Liu W; Deng Y; Ji X; Wu M; Yu M; Zhang H; Wang H; Thompson TC; Ni W; Cao G
    Cancer Prev Res (Phila); 2015 Oct; 8(10):978-88. PubMed ID: 26290395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.